Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Sarepta Therapeutics, Inc. - Common Stock (NQ:SRPT)

17.14 -0.50 (-2.86%)
Streaming Delayed Price Updated: 10:38 AM EST, Nov 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,021,055
Open 17.77
Bid (Size) 17.11 (300)
Ask (Size) 17.15 (200)
Prev. Close 17.64
Today's Range 17.05 - 17.95
52wk Range 10.41 - 138.81
Shares Outstanding 93,148,652
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
10 Health Care Stocks Whale Activity In Today's Session
 
Via Benzinga
Analyst Ratings Send Ripples Through Markets: Sarepta's Resilience vs. Pinterest's Plunge
The financial markets are a complex ecosystem, constantly reacting to a myriad of inputs, from macroeconomic data to geopolitical shifts. Among the most closely watched catalysts are the pronouncements... 
Via MarketMinute

Performance

YTD
-86.2%
-86.2%
1 Month
-25.9%
-25.9%
3 Month
-4.6%
-4.6%
6 Month
-53.1%
-53.1%
1 Year
-86.6%
-86.6%

More News

Read More
This Sarepta Therapeutics Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday
Via Benzinga
Sarepta Therapeutics Shares Plummet as Key DMD Treatments Miss Primary Endpoint in Late-Stage Trial
Via MarketMinute
Topics Death
Sarepta Therapeutics Stock Crashes After-Hours On DMD Trial Failure, Q3 Print — Retail Still Sees Long-Term Comeback
Via Stocktwits
Which stocks are experiencing notable movement on Tuesday?
Via Chartmill
Gold Falls Over 1%; Uber Shares Decline After Q3 Results
Via Benzinga
Sarepta Faces Investor Skepticism As Duchenne Data Falls Short Of Statistical Significance
Via Benzinga
Tuesday's session: top gainers and losers
Via Chartmill
Earnings Scheduled For November 3, 2025
Via Benzinga
A Peek at Sarepta Therapeutics's Future Earnings
Via Benzinga
Sarepta Stock Dumps: Pharma Bro Martin Shkreli Still Likes It
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
These stocks are gapping in today's session
Via Chartmill
Insperity Posts Downbeat Q3 Results, Joins IAC, Archer-Daniels-Midland And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Via Benzinga
Tuesday's pre-market session: top gainers and losers
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Dow Futures Edge Lower On Pullback Fears: PLTR, SRPT, TSLA, AMD Among Stocks To Watch
Via Stocktwits
Topics ETFs Stocks
Why Upwork Shares Are Trading Higher By Over 22%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Sarepta Therapeutics Stock Is Tumbling After The Close: Here's Why
Via Benzinga
These stocks are moving in today's after hours session
Via Chartmill
Sarepta Crashes After Two Muscular Dystrophy Drugs Fail Confirmatory Tests
Via Investor's Business Daily
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Sarepta Therapeutics Announces Third Quarter 2025 Financial Results and Recent Corporate Developments, Including Completion of Its Confirmatory Study, ESSENCE
From Sarepta Therapeutics, Inc.
Via Business Wire
Top Stocks With Earnings This Week: Joby, IonQ, AMD and More
Via Benzinga

Frequently Asked Questions

Is Sarepta Therapeutics, Inc. - Common Stock publicly traded?
Yes, Sarepta Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Sarepta Therapeutics, Inc. - Common Stock trade on?
Sarepta Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Sarepta Therapeutics, Inc. - Common Stock?
The ticker symbol for Sarepta Therapeutics, Inc. - Common Stock is SRPT on the Nasdaq Stock Market
What is the current price of Sarepta Therapeutics, Inc. - Common Stock?
The current price of Sarepta Therapeutics, Inc. - Common Stock is 17.14
When was Sarepta Therapeutics, Inc. - Common Stock last traded?
The last trade of Sarepta Therapeutics, Inc. - Common Stock was at 11/07/25 10:38 AM ET
What is the market capitalization of Sarepta Therapeutics, Inc. - Common Stock?
The market capitalization of Sarepta Therapeutics, Inc. - Common Stock is 1.60B
How many shares of Sarepta Therapeutics, Inc. - Common Stock are outstanding?
Sarepta Therapeutics, Inc. - Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.